Case Study: Phase III Psoriasis

A leading global pharmaceutical company with a focus on dermatology selected Novella Clinical’s Dermatology Division to conduct a large Phase III psoriasis study involving over 1,100 patients at 60 sites. Novella was challenged to achieve the sponsor’s goal of randomizing 1,152 patients in a nine-month period. Novella’s patient recruitment process and predictive enrollment expertise dramatically reduced enrollment timelines by 44% and budget was maintained.